Publication: 2384

Publication: 2384

Randomized Phase II Study of Everolimus (E) versus Everolimus plus Bevacizumab (E+B) in Patients (Pts) with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance)

URL

URL

Google Scholar

Citation:: Pancreas vol 45 (3) abstr C23

Meeting Instance:: NANETS 2015
Year:: 2016
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3473

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, CA31946, CA025224

Corr. Author:
Authors:: Matthew H. Kulke Donna Niedzwiecki Nathan R. Foster Briant Fruth Pamela L. Kunz Hagen Kennecke Edward M. Woli Alan P. Venook

Networks:: CA824, LAPS-CT018, LAPS-MA036, LAPS-MN026, OR013

Study: CALGB-80701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: